J&J Says Penalties In Arkansas Risperdal Case ‘Excessive,’ Seeks New Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Argues that Arkansas Medicaid spent less than $10 million on Risperdal, but the fine imposed by a state judge for deceptive marketing practices would exceed $1.2 billion.